Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA): An overview and update for the cytopathologist

Cancer Cytopathology

Volumn 122, Issue 8, 2014, Pages 561-576

  VanderLaan, Paul A ^a,b   Wang, Helen H ^a   Majid, Adnan ^a   Folch, Erik ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cost effectiveness; Cytology; EBUS TBNA; Endobronchial ultrasound guided transbronchial needle aspiration; Fine needle aspiration; FNA; Lung cancer staging; Lymph node; Sample adequacy

Indexed keywords

COST EFFECTIVENESS; CYTOLOGY; EBUS-TBNA; ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION; FINE-NEEDLE ASPIRATION; FNA; LUNG CANCER STAGING; LYMPH NODE; SAMPLE ADEQUACY;

BRONCHOSCOPY; COST-BENEFIT ANALYSIS; ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MEDIASTINUM; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 84905231053     PISSN: 1934662X     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21431     Document Type: Review

References (100)

1. American Cancer Society. Cancer Facts & Figures 2013. Atlanta, GA: American Cancer Society; 2013.
2. Gospodarowicz MK, Miller D, Groome PA, Greene FL, Logan PA, Sobin LH. The process for continuous improvement of the TNM classification. Cancer. 2004;100:1-5.
3. Medford AR, Bennett JA, Free CM, Agrawal S. Endobronchial ultrasound guided transbronchial needle aspiration. Postgrad Med J. 2010;86:106-115.
4. Kokkonouzis I, Strimpakos AS, Lampaditis I, Tsimpoukis S, Syrigos KN. The role of endobronchial ultrasound in lung cancer diagnosis and staging: A comprehensive review. Clin Lung Cancer. 2012;13:408-415.
5. Low A, Medford AR. Endobronchial ultrasound-guided transbronchial needle aspiration. Rev Recent Clin Trials. 2013;8:61-71.
6. Cameron SE, Andrade RS, Pambuccian SE. Endobronchial ultrasound-guided transbronchial needle aspiration cytology: A state of the art review. Cytopathology. 2010;21:6-26.
7. Schieppati E. Mediastinal puncture thru the tracheal carina. Rev Assoc Med Argent. 1949;63:497-499.
8. Wang KP, Brower R, Haponik EF, Siegelman S. Flexible transbronchial needle aspiration for staging of bronchogenic carcinoma. Chest. 1983;84:571-576.
9. Holty JE, Kuschner WG, Gould MK. Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: A meta-analysis. Thorax. 2005;60:949-955.
10. Hurter T, Hanrath P. Endobronchial sonography: feasibility and preliminary results. Thorax. 1992;47:565-567.
11. Mathis G. Thoraxsonography-Part I: chest wall and pleura. Ultrasound Med Biol. 1997;23:1131-1139.
12. Herth F, Becker HD. Endobronchial ultrasound. In: Mathis G, Lessnau KD, eds. Atlas of Chest Sonography. Heidelberg, Germany: Springer-Verlag; 2003:ix, 179.
13. Tharian B, Tsiopoulos F, George N, Pietro SD, Attili F, Larghi A. Endoscopic ultrasound fine needle aspiration: Technique and applications in clinical practice. World J Gastrointest Endosc. 2012;4: 532-544.
14. Leschber G, Sperling D, Klemm W, Merk J. Does videomediastinoscopy improve the results of conventional mediastinoscopy? Eur J Cardiothorac Surg. 2008;33:289-293.
15. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. Invasive mediastinal staging of lung cancer: ACCP evidencebased clinical practice guidelines (2nd edition). Chest. 2007;132: 202S-220S.
16. Folch E, Santacruz JF, Machuzak MS, Gildea T, Majid A. Safety and efficacy of EBUS-guided TBNA through the pulmonary artery: A preliminary report. Chest. 2011;140:600A.
17. Herth FJ, Lunn W, Eberhardt R, Becker HD, Ernst A. Transbronchial versus transesophageal ultrasound-guided aspiration of enlarged mediastinal lymph nodes. Am J Respir Crit Care Med. 2005;171:1164-1167.
18. Hwangbo B, Lee GK, Lee HS, et al. Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer. Chest. 2010;138:795-802.
19. Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer. TNM Classification of Malignant Tumours. 7th ed. Chichester, United Kingdom; Wiley-Blackwell; 2010.
20. Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd edition: American College of Chest Physicians evidencebased clinical practice guidelines. Chest. 2013;143:e211S-e250S.
21. Pretreatment evaluation of non-small-cell lung cancer. The American Thoracic Society and The European Respiratory Society. Am J Respir Crit Care Med. 1997;156:320-332.
22. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg. 2007;32:1-8.
23. Alsharif M, Andrade RS, Groth SS, Stelow EB, Pambuccian SE. Endobronchial ultrasound-guided transbronchial fine-needle aspiration: The University of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties. Am J Clin Pathol. 2008;130:434-443.
24. Feller-Kopman D, Yung RC, Burroughs F, Li QK. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration: A retrospective study with histology correlation. Cancer. 2009;117: 482-490.
25. Szlubowski A, Herth FJ, Soja J, et al. Endobronchial ultrasoundguided needle aspiration in non-small-cell lung cancer restaging verified by the transcervical bilateral extended mediastinal lymphadenectomy- A prospective study. Eur J Cardiothorac Surg. 2010;37: 1180-1184.
26. Yasufuku K, Pierre A, Darling G, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 2011;142:1393-1400.
27. Lee BE, Kletsman E, Rutledge JR, Korst RJ. Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2012; 143:585-590.
28. Nakajima T, Yasufuku K, Saegusa F, et al. Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for nodal staging in patients with lung cancer. Ann Thorac Surg. 2013;95:1695-1699.
29. Karunamurthy A, Cai G, Dacic S, Khalbuss WE, Pantanowitz L, Monaco SE. Evaluation of endobronchial ultrasound-guided fineneedle aspirations (EBUS-FNA): correlation with adequacy and histologic follow-up. Cancer Cytopathol. 2014;122:23-32.
30. Herth FJ, Annema JT, Eberhardt R, et al. Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer. J Clin Oncol. 2008;26:3346-3350.
31. Chen F, Miyahara R, Sato T, et al. Usefulness of endobronchial ultrasound in patients with previously treated thoracic malignancy. Interact Cardiovasc Thorac Surg. 2012;14:34-37.
32. Domanski HA, Monsef N, Domanski AM. Lung. In: Atlas of Fine Needle Aspiration Cytology. Domanski HA, ed. London, United Kingdom: Springer-Verlag;2014:161-194.
33. Rice DC, Steliga MA, Stewart J, et al. Endoscopic ultrasoundguided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg. 2009;88:862-868; discussion 868-869.
34. Marshall CB, Jacob B, Patel S, et al. The utility of endobronchial ultrasound-guided transbronchial needle aspiration biopsy in the diagnosis of mediastinal lymphoproliferative disorders. Cancer Cytopathol. 2011;119:118-126.
35. Stoll LM, Yung RC, Clark DP, Li QK. Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration. Cancer Cytopathol. 2010; 118:278-286.
36. Baker JJ, Solanki PH, Schenk DA, Van Pelt C, Ramzy I. Transbronchial fine needle aspiration of the mediastinum. Importance of lymphocytes as an indicator of specimen adequacy. Acta Cytol. 1990;34:517-523.
37. Nayak A, Sugrue C, Koenig S, Wasserman PG, Hoda S, Morgenstern NJ. Endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA): A proposal for on-site adequacy criteria. Diagn Cytopathol. 2012;40:128-137.
38. Andrade RS, Odell DD, D'Cunha J, Maddaus MA. Endobronchial ultrasonography (EBUS)-its role in staging of non-small cell lung cancer and who should do it? J Thorac Cardiovasc Surg. 2012;144: S9-S13.
39. Whitson BA, Groth SS, Odell DD, et al. True negative predictive value of endobronchial ultrasound in lung cancer: Are we being conservative enough? Ann Thorac Surg. 2013;95:1689-1694.
40. Gu P, Zhao YZ, Jiang LY, Zhang W, Xin Y, Han BH. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis. Eur J Cancer. 2009;45:1389-1396.
41. Navani N, Brown JM, Nankivell M, et al. Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: A multicenter study of 774 patients. Am J Respir Crit Care Med. 2012; 185:1316-1322.
42. Miller DR, Mydin HH, Marshall AD, Devereux GS, Currie GP. Fatal haemorrhage following endobronchial ultrasound-transbronchial needle aspiration: An unfortunate first. QJM. 2013;106:295-296.
43. Steinfort DP, Hew MJ, Irving LB. Bronchoscopic evaluation of the mediastinum using endobronchial ultrasound: A description of the first 216 cases carried out at an Australian tertiary hospital. Intern Med J. 2011;41:815-824.
44. Ernst A, Silvestri GA, Johnstone D. Interventional pulmonary procedures: guidelines from the American College of Chest Physicians. Chest. 2003;123:1693-1717.
45. Bolliger CT, Mathur PN, Beamis JF, et al. ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J. 2002;19:356-373.
46. Block MI. Endobronchial ultrasound for lung cancer staging: how many stations should be sampled? Ann Thorac Surg. 2010;89:1582-1587.
47. Folch E, Majid A. Point: Are >50 supervised procedures required to develop competency in performing endobronchial ultrasoundguided transbronchial needle aspiration for mediastinal staging? Yes. Chest. 2013;143:888-891; discussion 894-895.
48. Du Rand IA, Barber PV, Goldring J, et al. British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults. Thorax. 2011;66(suppl 3):1-21.
49. Medford AR. Learning curve for endobronchial ultrasound-guided transbronchial needle aspiration [letter]. Chest 141:1643, 2012; author reply 1644.
50. Fernandez-Villar A, Leiro-Fernandez V, Botana-Rial M, Represas- Represas C, Nunez-Delgado M. The endobronchial ultrasoundguided transbronchial needle biopsy learning curve for mediastinal and hilar lymph node diagnosis. Chest. 2012;141:278-279.
51. Schmidt RL, Witt BL, Lopez-Calderon LE, Layfield LJ. The influence of rapid onsite evaluation on the adequacy rate of fine-needle aspiration cytology: A systematic review and meta-analysis. Am J Clin Pathol. 2013;139:300-308.
52. da Cunha Santos, G, Ko HM, Saieg MA, Geddie WR. "The petals and thorns" of ROSE (rapid on-site evaluation). Cancer Cytopathol. 2013;121:4-8.
53. da Cunha Santos, G. ROSEs (rapid on-site evaluations) to our patients: The impact on laboratory resources and patient care. Cancer Cytopathol. 2013;121:537-539.
54. Diacon AH, Schuurmans MM, Theron J, et al. Utility of rapid on-site evaluation of transbronchial needle aspirates. Respiration. 2005;72:182-188.
55. Collins BT, Chen AC, Wang JF, Bernadt CT, Sanati S. Improved laboratory resource utilization and patient care with the use of rapid on-site evaluation for endobronchial ultrasound fine-needle aspiration biopsy. Cancer Cytopathol. 2013;121:544-551.
56. Cermak TS, Wang B, DeBrito P, Carroll J, Haddad N, Sidawy MK. Does on-site adequacy evaluation reduce the nondiagnostic rate in endoscopic ultrasound-guided fine-needle aspiration of pancreatic lesions? Cancer Cytopathol. 2012;120:319-325.
57. Trisolini R, Cancellieri A, Tinelli C, et al. Rapid on-site evaluation of transbronchial aspirates in the diagnosis of hilar and mediastinal adenopathy: A randomized trial. Chest. 2011;139:395-401.
58. Oki M, Saka H, Kitagawa C, et al. Rapid on-site cytologic evaluation during endobronchial ultrasound-guided transbronchial needle aspiration for diagnosing lung cancer: A randomized study. Respiration. 2013;85:486-492.
59. Layfield LJ, Bentz JS, Gopez EV. Immediate on-site interpretation of fine-needle aspiration smears: A cost and compensation analysis. Cancer. 2001;93:319-322.
60. Saji H, Tsuboi M, Shimada Y, et al. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer. Chest. 2013; 143:1618-1625.
61. Kang CH, Ra YJ, Kim YT, Jheon SH, Sung SW, Kim JH. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Ann Thorac Surg. 2008;86:1092-1097.
62. Misthos P, Sepsas E, Kokotsakis J, Skottis I, Lioulias A. The significance of 1-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. Ann Thorac Surg. 2008;86:1626-1630.
63. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244-285.
64. Travis WD, Brambilla E, Noguchi M, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013;137:668-684.
65. Collins BT. Endobronchial ultrasound fine-needle aspiration biopsy of pulmonary non-small cell carcinoma with subclassification by immunohistochemistry panel. Cancer Cytopathol. 2013;121:146- 154.
66. Roh MH, Schmidt L, Placido J, et al. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma. Diagn Cytopathol. 2012;40:949-955.
67. Folch E, Yamaguchi N, Vanderlaan PA, et al. Adequacy of lymph node transbronchial needle aspirates using convex probe endobronchial ultrasound for multiple tumor genotyping techniques in nonsmall- cell lung cancer. J Thorac Oncol. 2013;8:1438-1444.
68. Nakajima T, Yasufuku K, Suzuki M, et al. Assessment of epidermal growth factor receptor mutation by endobronchial ultrasoundguided transbronchial needle aspiration. Chest. 2007;132:597-602.
69. Garcia-Olive I, Monso E, Andreo F, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for identifying EGFR mutations. Eur Respir J. 2010;35:391-395.
70. Schuurbiers OC, Looijen-Salamon MG, Ligtenberg MJ, van der Heijden, HF. A brief retrospective report on the feasibility of epidermal growth factor receptor and KRAS mutation analysis in transesophageal ultrasound- And endobronchial ultrasound-guided fine needle cytological aspirates. J Thorac Oncol. 2010;5:1664-1667.
71. van Eijk, R, Licht J, Schrumpf M, et al. Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR [serial online]. PLoS One. 2011;6:e17791.
72. Santis G, Angell R, Nickless G, et al. Screening for EGFR and KRAS mutations in endobronchial ultrasound derived transbronchial needle aspirates in non-small cell lung cancer using COLDPCR [serial online]. PLoS One. 2011;6:e25191.
73. Nakajima T, Yasufuku K, Nakagawara A, Kimura H, Yoshino I. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration. Chest. 2011;140:1319-1324.
74. Knoepp SM, Roh MH. Ancillary techniques on direct-smear aspirate slides: A significant evolution for cytopathology techniques. Cancer Cytopathol. 2013;121:120-128.
75. Steinfort DP, Conron M, Tsui A, et al. Endobronchial ultrasoundguided transbronchial needle aspiration for the evaluation of suspected lymphoma. J Thorac Oncol. 2010;5:804-809.
76. Kennedy MP, Jimenez CA, Bruzzi JF, et al. Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lymphoma. Thorax. 2008;63:360-365.
77. Farmer PL, Bailey DJ, Burns BF, Day A, LeBrun DP. The reliability of lymphoma diagnosis in small tissue samples is heavily influenced by lymphoma subtype. Am J Clin Pathol. 2007;128:474- 480.
78. de Tute, RM. Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies. Histopathology. 2011;58:90-105.
79. Fromm JR, Thomas A, Wood BL. Flow cytometry can diagnose classical Hodgkin lymphoma in lymph nodes with high sensitivity and specificity. Am J Clin Pathol. 2009;131:322-332.
80. Ko HM, da Cunha Santos, G, Darling G, et al. Diagnosis and subclassification of lymphomas and non-neoplastic lesions involving mediastinal lymph nodes using endobronchial ultrasound-guided transbronchial needle aspiration. Diagn Cytopathol. 2013;41:1023- 1030.
81. Navani N, Booth HL, Kocjan G, et al. Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis. Respirology. 2011;16:467-472.
82. Nakajima T, Yasufuku K, Kurosu K, et al. The role of EBUSTBNA for the diagnosis of sarcoidosis-comparisons with other bronchoscopic diagnostic modalities. Respir Med. 2009;103:1796- 1800.
83. von Bartheld, MB, Dekkers OM, Szlubowski A, et al. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: The GRANULOMA randomized clinical trial. JAMA. 2013; 309:2457-2464.
84. Tremblay A, Stather DR, Maceachern P, Khalil M, Field SK. A randomized controlled trial of standard vs endobronchial ultrasonography-guided transbronchial needle aspiration in patients with suspected sarcoidosis. Chest. 2009;136:340-346.
85. Hassan T, McLaughlin AM, O'Connell F, Gibbons N, Nicholson S, Keane J. EBUS-TBNA performs well in the diagnosis of isolated thoracic tuberculous lymphadenopathy. Am J Respir Crit Care Med. 2011;183:136-137.
86. Navani N, Molyneaux PL, Breen RA, et al. Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: A multicentre study. Thorax. 2011;66:889-893.
87. Khazai L, Kundu UR, Jacob B, et al. Endobronchial ultrasoundguided transbronchial needle aspiration biopsy is useful evaluating mediastinal lymphadenopathy in a cancer center [serial online]. CytoJournal. 2011;8:10.
88. Gailey MP, Klutts JS, Jensen CS. Fine-needle aspiration of histoplasmosis in the era of endoscopic ultrasound and endobronchial ultrasound: cytomorphologic features and correlation with clinical laboratory testing. Cancer Cytopathol. 2013;121:508-517.
89. Harley DP, Krimsky WS, Sarkar S, Highfield D, Aygun C, Gurses B. Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: An alternative strategy. Ann Thorac Surg. 2010;89:368-373; discussion 373- 374.
90. Galluccio G, Lucantoni G. Mediastinal bronchogenic cyst's recurrence treated with EBUS-FNA with a long-term follow-up. Eur J Cardiothorac Surg. 2006;29:627-629; discussion 629.
91. Weinstein MC, Torrance G, McGuire A. QALYs: The basics. Value Health. 2009;12(suppl 1):S5-S9.
92. Neumann PJ, Weinstein MC. Legislating against use of costeffectiveness information. N Engl J Med. 2010;363:1495-1497.
93. 111th US Congress. An act entitled The Patient Protection and Affordable Care Act. Public Law 111-148. Approved March 23, 2010. Washington, DC: US Government Printing Office; 2010.
94. Woodward RM, Menzin J, Neumann PJ. Quality-adjusted life years in cancer: pros, cons, and alternatives. Eur J Cancer Care (Engl). 2013;22:12-19.
95. Rintoul RC, Glover MJ, Jackson C, et al. Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: A health economics analysis of the ASTER trial from a European perspective [published online ahead of print September 24, 2013]. Thorax. 2013. doi: 10.1136/thoraxjnl-2013-204374.
96. Sogaard R, Fischer BM, Mortensen J, Rasmussen TR, Lassen U. The optimality of different strategies for supplemental staging of non-small-cell lung cancer: A health economic decision analysis. Value Health. 2013;16:57-65.
97. McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics. 2008;26:733-744.
98. Ang SY, Tan RW, Koh MS, Lim J. Economic analysis of endobronchial ultrasound (EBUS) as a tool in the diagnosis and staging of lung cancer in Singapore. Int J Technol Assess Health Care. 2010; 26:170-174.
99. Steinfort DP, Liew D, Conron M, Hutchinson AF, Irving LB. Costbenefit of minimally invasive staging of non-small cell lung cancer: A decision tree sensitivity analysis. J Thorac Oncol. 2010;5:1564-1570.
100. Sharples LD, Jackson C, Wheaton E, et al. Clinical effectiveness and cost-effectiveness of endobronchial and endoscopic ultrasound relative to surgical staging in potentially resectable lung cancer: results from the ASTER randomised controlled trial. Health Technol Assess. 2012;16:1-75.